HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stuart Montgomery Selected Research
Stuart Montgomery Research Topics
Disease
33
Major Depressive Disorder (Major Depressive Disorders)
01/2023 - 01/2005
13
Treatment-Resistant Depressive Disorder
01/2023 - 07/2007
6
Panic Disorder (Panic Attack)
12/2020 - 07/2007
5
Social Phobia
12/2020 - 07/2007
5
Anxiety Disorders (Anxiety Disorder)
01/2017 - 11/2008
4
Bipolar Disorder (Manic Depressive Psychosis)
01/2022 - 11/2007
4
Depressive Disorder (Melancholia)
01/2019 - 07/2007
3
Schizophrenia (Dementia Praecox)
01/2022 - 11/2017
3
Mood Disorders (Mood Disorder)
01/2022 - 09/2013
3
Agoraphobia
12/2020 - 01/2017
2
Weight Gain
01/2023 - 01/2019
2
Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
11/2022 - 01/2017
2
Hypertension (High Blood Pressure)
01/2022 - 01/2019
2
Genetic Risk Score
01/2022 - 01/2021
2
Mental Disorders (Mental Disorder)
01/2021 - 10/2017
2
Personality Disorders (Personality Disorder)
01/2019 - 07/2007
1
Inflammation (Inflammations)
10/2021
1
Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
12/2020
1
Neurobehavioral Manifestations
01/2019
1
Psychomotor Agitation (Akathisia)
01/2019
1
Hypothyroidism
01/2018
1
Bulimia Nervosa
01/2017
1
Phobic Disorders (Phobia)
01/2017
1
Postpartum Depression (Post-Natal Depression)
11/2016
1
Disease Susceptibility (Diathesis)
11/2016
1
Sleep Initiation and Maintenance Disorders (Insomnia)
04/2015
1
Constipation
04/2015
1
Dizziness (Lightheadedness)
10/2013
1
Medically Unexplained Symptoms
11/2008
1
Mania (Manias)
11/2007
Drug/Important Bio-Agent (IBA)
35
Antidepressive Agents (Antidepressants)
IBA
01/2023 - 07/2007
9
Antipsychotic Agents (Antipsychotics)
IBA
11/2022 - 01/2017
5
Pregabalin (Lyrica)
FDA Link
01/2022 - 11/2008
5
Venlafaxine Hydrochloride (Effexor)
FDA Link
Generic
01/2019 - 01/2005
5
Escitalopram
FDA Link
12/2017 - 01/2005
4
Quetiapine Fumarate (Seroquel)
FDA Link
11/2022 - 05/2013
4
Benzodiazepines
IBA
12/2020 - 01/2017
4
Brain-Derived Neurotrophic Factor (BDNF)
IBA
01/2019 - 01/2011
2
Psychotropic Drugs (Psychoactive Drugs)
IBA
01/2023 - 01/2022
2
Aripiprazole (Abilify)
FDA Link
11/2022 - 01/2019
2
Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)
IBA
06/2022 - 08/2011
2
cariprazine
IBA
01/2019 - 11/2017
2
Citalopram
FDA Link
Generic
08/2011 - 03/2011
1
Serotonin (5 Hydroxytryptamine)
IBA
01/2023
1
Serotonin and Noradrenaline Reuptake Inhibitors
IBA
01/2023
1
Norepinephrine (Noradrenaline)
FDA Link
Generic
01/2023
1
Glycogen Synthase Kinase 3 beta
IBA
10/2021
1
fasudil (AT 877)
IBA
10/2021
1
rho-Associated Kinases
IBA
10/2021
1
Chromatin
IBA
01/2019
1
CMP- N- acetylneuraminate- poly- alpha- 2,8- sialosyl sialyltransferase
IBA
01/2019
1
Olanzapine (Zyprexa)
FDA Link
01/2019
1
Biomarkers (Surrogate Marker)
IBA
01/2019
1
brexpiprazole
IBA
01/2019
1
Lurasidone Hydrochloride
FDA Link
01/2019
1
ziprasidone (Geodon)
FDA Link
01/2019
1
3,4-methylenedioxyethamphetamine (MDEA)
IBA
01/2019
1
lumateperone
IBA
01/2019
1
Lithium
IBA
12/2018
1
Tuberculin (PPD)
IBA
11/2016
1
Vortioxetine
IBA
04/2015
1
Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)
IBA
09/2013
1
Cytochrome P-450 CYP2C19
IBA
08/2013
1
Cytochrome P-450 Enzyme System (Cytochrome P450)
IBA
08/2013
1
Cytochrome P-450 CYP1A2 (CYP1A2)
IBA
08/2013
1
Cytochrome P-450 CYP2D6 (CYP2D6)
IBA
08/2013
1
Cytochrome P-450 CYP2C9
IBA
08/2013
1
Carrier Proteins (Binding Protein)
IBA
07/2013
1
Elements
IBA
07/2013
1
Cyclic AMP (AMP, Cyclic)
IBA
07/2013
1
Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)
IBA
07/2013
1
Desipramine (Pertofrane)
FDA Link
Generic
08/2011
1
Dysbindin
IBA
12/2010
1
Anti-Anxiety Agents (Anxiolytics)
IBA
11/2008
1
Desvenlafaxine Succinate
FDA Link
09/2008
1
Methylphenidate (Ritalin)
FDA Link
Generic
11/2007
1
Substance P
IBA
02/2006
1
Aprepitant (Emend)
FDA Link
02/2006
Therapy/Procedure
2
Therapeutics
01/2021 - 09/2013
1
Precision Medicine
01/2019
1
Drug Therapy (Chemotherapy)
12/2018
1
Secondary Prevention
11/2007